Marker Therapeutics Inc.

NASDAQ: MRKR · Real-Time Price · USD
1.14
0.01 (0.88%)
At close: May 23, 2025, 3:59 PM
1.15
0.88%
After-hours: May 23, 2025, 04:57 PM EDT
0.88%
Bid 1.05
Market Cap 12.9M
Revenue (ttm) 5.7M
Net Income (ttm) -12.78M
EPS (ttm) -1.19
PE Ratio (ttm) -0.96
Forward PE -0.38
Analyst Strong Buy
Ask 1.22
Volume 15,807
Avg. Volume (20D) 109,239
Open 1.10
Previous Close 1.13
Day's Range 1.10 - 1.14
52-Week Range 0.95 - 5.99
Beta 1.29

About MRKR

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MRKR
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MRKR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Marker Therapeutics has released their quartely earnings on May 15, 2025:
  • Revenue of $349.1K misses estimates by $650.9K, with -71.94% YoY decline.
  • EPS of -0.4 misses estimates by -0.08, with -48.15% YoY decline.
  • Next Earnings Release

    Marker Therapeutics Inc. is scheduled to release its earnings on May 30, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    2 months ago
    +33.33%
    Marker Therapeutics shares are trading higher afte... Unlock content with Pro Subscription
    5 months ago
    -7.44%
    Marker Therapeutics shares are trading lower. The company reported results from its Phase 1 APOLLO study of MT-601 in relapsed Lymphoma.
    No News article available yet